‘There’s this deep mystery of what, actually, is this thing?’: the philosopher inside Google DeepMind AI
By Robert P. Baird,
The Guardian
| 06. 30. 2026
In 2017, a 33-year-old political philosopher named Iason Gabriel was told by a friend that he ought to apply for a job at DeepMind, the London-based subsidiary of Google where much of its AI research was concentrated. The suggestion was not an obvious one.
Gabriel was a cheerful but intense junior academic with a passion for Vipassana meditation and what his brother calls “enthusiastic” rock climbing. The eldest son of a Greek management professor and a British documentary maker, Gabriel split his time between teaching and international development work. At the University of Oxford, where he was a fellow at St John’s College, Gabriel taught courses on political theory and wrote papers on the moral contortions of “yuppie ethics” and the ethical blind spots of effective altruism. When he wasn’t there, he did crisis work for the United Nations Development Programme in Sudan and Lebanon.
DeepMind, meanwhile, was the world’s leading AI research lab. In part, this was because it had the financial and computational backing of Google, which had bought the company in 2014 for $650m. In part, it was...
Related Articles
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Sarah Norcross, Sandy Starr, Amanda Cooney, and Anneliese Burton, BioNews | 07.06.2026
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...